![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
SL Walsh and GC Wagner
Psychology Department, Rutgers University, New Brunswick, New Jersey.
Methamphetamine is a psychomotor stimulant which, given in high doses, produces neurodegenerative changes in the dopamine and serotonin systems. This study was designed to assess motoric deficits in the rat following a high-dose regimen of methamphetamine. Long-Evans male rats received either four injections of saline or methamphetamine (12.5 mg/kg, every 2 hr), a dose sufficient to produce 45 and 36% reductions in striatal dopamine and serotonin, respectively. Before treatment, subjects were trained to perform one of the following motor tasks: one- way active avoidance, inhibitory avoidance, rotorod or the balance beam. After recovery, performance under base-line and drug challenge conditions revealed that methamphetamine treatment caused significant deficits in active avoidance performance (24% increase in response latency) and balance beam performance (2- to 3-fold increase in footfalls), but had no effect on inhibitory avoidance or rotorod performance. Administration of l-dopa (100 mg/kg) significantly improved the methamphetamine-treated subjects' performance on the balance beam, but had no effect on the control subjects' performance. The methamphetamine-treated subjects exhibited a significant decrease in sensitivity to the effects of fenfluramine in comparison to the controls on both the rotorod and active avoidance tasks. We conclude that high-dose methamphetamine treatment produces long-lasting motor deficits associated with chronic reductions of striatal dopamine and serotonin. These data and the utility of the motor tasks are discussed in reference to a laboratory model of Parkinson's disease.
This article has been cited by other articles:
|
|
 |
|
  M. S. Goldberg, S. M. Fleming, J. J. Palacino, C. Cepeda, H. A. Lam, A. Bhatnagar, E. G. Meloni, N. Wu, L. C. Ackerson, G. J. Klapstein, et al. Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons J. Biol. Chem., October 31, 2003; 278(44): 43628 - 43635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Chapman, G. R. Hanson, R. P. Kesner, and K. A. Keefe Long-Term Changes in Basal Ganglia Function after a Neurotoxic Regimen of Methamphetamine J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 520 - 527. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. D. Volkow, L. Chang, G.-J. Wang, J. S. Fowler, D. Franceschi, M. J. Sedler, S. J. Gatley, R. Hitzemann, Y.-S. Ding, C. Wong, et al. Higher Cortical and Lower Subcortical Metabolism in Detoxified Methamphetamine Abusers Am J Psychiatry, March 1, 2001; 158(3): 383 - 389. [Abstract] [Full Text]
|
|
|
|
|
|
K. E. Sabol, J. B. Richards, and K. Yung The Effects of High-Dose Methamphetamine in the Aging Rat: Differential Reinforcement of Low-Rate 72-s Schedule Behavior and Neurochemistry J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 850 - 863. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. L. Wallace, G. A. Gudelsky, and C. V. Vorhees Methamphetamine-Induced Neurotoxicity Alters Locomotor Activity, Stereotypic Behavior, and Stimulated Dopamine Release in the Rat J. Neurosci., October 15, 1999; 19(20): 9141 - 9148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-I Tsao, B. Ladenheim, A. M. Andrews, C. C. Chiueh, J. L. Cadet, and T.-P. Su Delta Opioid Peptide [D-Ala2,D-leu5]Enkephalin Blocks the Long-term Loss of Dopamine Transporters Induced by Multiple Administrations of Methamphetamine: Involvement of Opioid Receptors and Reactive Oxygen Species J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 322 - 331. [Abstract] [Full Text]
|
|
|
|
|
|
E. P. Brandon, S. F. Logue, M. R. Adams, M. Qi, S. P. Sullivan, A. M. Matsumoto, D. M. Dorsa, J. M. Wehner, G. S. McKnight, and R. L. Idzerda Defective Motor Behavior and Neural Gene Expression in RIIbeta -Protein Kinase A Mutant Mice J. Neurosci., May 15, 1998; 18(10): 3639 - 3649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Cass Decreases in Evoked Overflow of Dopamine in Rat Striatum after Neurotoxic Doses of Methamphetamine J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 105 - 113. [Abstract] [Full Text]
|
|
|
|
|
|
W. A. Cass GDNF Selectively Protects Dopamine Neurons over Serotonin Neurons Against the Neurotoxic Effects of Methamphetamine J. Neurosci., December 15, 1996; 16(24): 8132 - 8139. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
